Try our Advanced Search for more refined results

Amyris, Inc.

Track this case

Case overview

Case Number:

1:23-bk-11131

Court:

Delaware

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. December 07, 2023

    Amyris Files Ch. 11 Plan With $23M Creditor Deal

    Biochemical company Amyris Inc. has filed a Chapter 11 plan disclosure statement saying it has reached a deal that could provide more than $23 million to unsecured creditors but that the proceeds of last week's auction of its brand assets were less than expected.

  2. November 21, 2023

    Amyris Woos 16 Bidders For Consumer Brands, Nears Auction

    Bankrupt biochemical company Amyris Inc. said on Tuesday that it has 16 suitors for its consumer products brands and plans an auction beginning next week, as it hopes to put forth a Chapter 11 plan in the coming days after resolving some objections raised by equity and debt investors in the contentious case.

  3. November 15, 2023

    Insurer Says Amryis' Ch. 11 Plan Missing Info On $800K Bonds

    An insurer for Amyris Inc. asked a Delaware judge to reject the biotech's Chapter 11 plan disclosure statement, saying that the proposed reorganization plan does not account for $800,000 in surety bonds that can't be transferred without the insurer's approval.

  4. November 08, 2023

    Naomi Watts Says Amyris Owes Her For Work on Wellness Co.

    British actress Naomi Watts told a Delaware court that bankrupt biochemical company Amyris Inc. owes her $270,000, not $0, for her work as the chief creative officer of Stripes, a perimenopause wellness brand founded by Watts and owned by Amyris.

  5. November 02, 2023

    Noteholders Want Biotech Co.'s Ch. 11 Circumstances Probed

    An ad hoc group of biotechnology company Amyris Inc. noteholders and shareholders asked a Delaware bankruptcy judge to appoint an examiner in the Chapter 11 case to probe actions of the company's leadership before and after it filed for bankruptcy.

  6. October 26, 2023

    Amyris Creditor Claims Doerr Schemed To Seize IP

    A cannabinoid maker has filed a suit accusing an entity affiliated with billionaire venture capital investor L. John Doerr of manipulating a loan to bankrupt biochemical company Amyris in order to seize its intellectual property rights back from the cannabinoid maker.

  7. October 25, 2023

    Amyris Noteholders Tag Doerr In Ch. 11 Discovery Push

    Noteholders of bankrupt biochemical company Amyris are seeking to force the company's lenders to turn over communications from billionaire venture capital investor John Doerr as the creditors pursue potential derivative lawsuits against current and former executives.

  8. October 11, 2023

    Amyris Junior Creditors Waived Ch. 11 DIP Lien Protection

    Junior creditors of biochemical company Amyris Inc. waived their rights to seek adequate protection payments in the company's Chapter 11 case, a Delaware bankruptcy judge ruled Wednesday, because they signed a subordination agreement that gave up those rights.

  9. October 04, 2023

    Amyris Says $190M Ch. 11 Loan Should Get Senior Lien

    Biochemical company Amyris Inc. on Tuesday asked a Delaware bankruptcy judge to reject arguments the that cannabinoid maker Lavvan Inc. holds senior claims to Amyris' Chapter 11 lender, saying a loss on the motion would jeopardize the company's existence.

  10. September 14, 2023

    Amyris Fails To Get Final OK On $190M DIP Loan

    Bankrupt biochemical company Amyris Inc. failed to get final court approval Thursday for its $190 million post-petition financing after cannabinoid maker and creditor Lavvan Inc. raised a series of issues that a Delaware bankruptcy judge said he found troubling.